Hologic, Inc. HOLX NASDAQ

Hologic, Inc. (HOLX) reported total assets of $9.01B and total liabilities of $3.97B for fiscal year 2025, resulting in total equity of $5.05B.

The company held $2.2B in cash and short-term investments. Total debt stood at $2.63B, with net debt of $667.3M. The Debt-to-Equity (D/E) ratio was 0.52 (moderate).

Current ratio is 3.75, indicating strong short-term liquidity. Interest coverage is 16.7x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.52, current ratio of 3.75, interest coverage 16.7x — balance sheet is strong
• MOAT (76/100) — Total assets $9.01B and equity $5.05B support the company's competitive scale
• VALUE (35/100) — Debt-to-Equity 0.52 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 57/100 with 3/7 criteria passed.

BDX

Becton, Dickinson and Company

$155.73

+0.19%

ALC

Alcon Inc.

$79.94

+0.25%

RMD

ResMed Inc.

$230.69

+0.19%

WST

West Pharmaceutical Services, Inc.

$267.93

+3.07%

COO

The Cooper Companies, Inc.

$71.61

-0.13%

ATR

AptarGroup, Inc.

$131.01

-0.83%

TFX

Teleflex Incorporated

$125.21

+1.65%

NVST

Envista Holdings Corp

$27.38

+1.75%